BLK and systemic lupus erythematosus: We have shown that distal enhancers influence the coordinated inverse expression of BLK and FAM167A: the SLE risk haplotype causes lower expression of BLK and higher expression of FAM167A (166), thereby providing multiple actions to consider that may or may not be responsible for altering SLE risk.